價格 | 詢價 | ||
包裝 | 1支 | 1支 | 1支 |
最小起訂量 | 1支 |
發(fā)貨地 | 湖北 |
更新日期 | 2025-04-24 |
中文名稱:匹那妥珠單抗 | 英文名稱:Pinatuzumab |
CAS:1313706-14-7 | 純度規(guī)格: PAGE:>95% |
產品類別: 藥物對照抗體 | |
抗體名: Pinatuzumab | 靶點: Sialic acid-binding Ig-like lectin 2, Siglec-2, CD22, T-cell surface antigen Leu-14, BL-CAM, SIGLEC2, B-lymphocyte cell adhesion molecule, B-cell receptor CD22 |
宿主: Humanized | 適應物種: Human |
克隆性: Monoclonal | 藥物對照抗體: Pinatuzumab |
Tags:Pinatuzumab 代理商,Pinatuzumab 價格,Pinatuzumab 供應商, Pinatuzumab supplier,Pinatuzumab purchase,Pinatuzumab 購買,Pinatuzumab 銷售
Catalog No.
DHD38506
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95%
Clonality
Monoclonal
Isotype
IgG1-kappa
Applications
Research Grade Biosimilar
Target
Sialic acid-binding Ig-like lectin 2, Siglec-2, CD22, T-cell surface antigen Leu-14, BL-CAM, SIGLEC2, B-lymphocyte cell adhesion molecule, B-cell receptor CD22
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P20273
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (5年) | 注冊資本 | 500萬 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術服務 | 經(jīng)營模式 | 試劑 |
產品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥30000 |
VIP5年
|
武漢維斯爾曼生物工程有限公司
|
2025-04-11 | |
¥4100 |
VIP4年
|
湖北魏氏化學試劑股份有限公司
|
2025-04-23 | |
詢價 |
VIP4年
|
江西瑞威爾生物科技有限公司
|
2025-04-07 |